School of Medicine
Showing 451-500 of 707 Results
-
Philip Oyer
Roy B. Cohn-Theodore A. Falasco Professor of Cardiothoracic Surgery, Emeritus
Current Research and Scholarly InterestsDevelopment of an artificial heart assist device; heart, and heart-lung transplantation.
-
Latha Palaniappan, MD, MS
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Palaniappan has published over 200 peer reviewed manuscripts, abstracts, and book chapters over the last 20 years in the areas of chronic disease prevention and treatment in diverse populations. She has expertise in epidemiological research using big data, use of electronic health records for research, and clinical trials.
-
Alan C. Pao
Associate Professor of Medicine (Nephrology) and, by courtesy, of Urology
Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.
-
Vedant Pargaonkar
Basic Life Research Scientist, Medicine - Med/Cardiovascular Medicine
BioMy long-term research interests involve development of algorithms using computational methods for early detection of coronary pathophysiology including, endothelial dysfunction and microvascular dysfunction (MVD) and/or a myocardial bridge (MB) in patients with angina and no obstructive coronary artery disease (NOCAD) and the identification of novel target therapies for primary prevention and improved prognosis in these patients. Under the mentorship of Dr. Jennifer Tremmel in Cardiovascular medicine at Stanford, I have been systematically studying to better understand the underlying pathophysiology of these patients, as well as the optimal use of diagnostic testing and treatment using the angina and no-obstructive CAD Registry at Stanford. In collaboration with other investigators in this field, we have published multiple scientific articles highlighting the limitations of current testing in this population and identification of novel diagnostic tools for early diagnosis and management of patients with angina and no obstructive CAD. My research also focuses on myocardial infarction (MI) in women, particularly spontaneous coronary artery dissection (SCAD). I have been involved in the design and execution of the first international collaborative study in SCAD, investigating peripartum vs. non-peripartum SCAD. This is analyzing the largest cohort of patients recruited from multiple US and non-US sites to understand the pathophysiological differences in these patient cohorts.
-
Victoria Parikh
Associate Professor of Medicine (Cardiovascular Medicine)
BioDr. Parikh is a clinician scientist who cares for patients with and studies inherited (genetic) cardiovascular disease. She is the director of the Stanford Center for Inherited Cardiovascular Disease (SCICD) which is one of the largest of its kind in the country. SCICD integrates clinical and basic science with the expert care of patients with genetic cardiovascular conditions (e.g., cardiomyopathies, arrhythmias and vascular diseases). It provides cutting edge care for thousands of patients and families across the lifespan and integrates medical, surgical and genetics care. Our team includes physicians, nurses, advanced practice providers, genetic counselors, exercise physiologists and scientists.
Dr. Parikh's own clinical practice and laboratory are focused on the genetics of cardiomyopathies and their associated arrhythmogenic substrates. She completed clinical cardiology fellowship at Stanford School of Medicine and her medical residency at the University of California, San Francisco. Funded by multiple research grants from the NIH, her lab seeks to identify novel mechanisms and therapeutic technologies for genetic cardiomyopathy as well as better understand the natural histories of patients affected by these diseases. -
Shyon Parsa
Affiliate, Department Funds
Resident in MedicineBioShyon earned his B.S. in Biomedical Engineering from the Cockrell School of Engineering at the University of Texas - Austin, graduating with Honors. He completed coursework in Thermodynamics and Transport Phenomena in Living Systems at the Department of Applied Mathematics and Theoretical Physics at Cambridge University under Clare Hall fellow Dr. Kenneth Diller. After graduation, Shyon enrolled in medical school at UT Southwestern, and graduated with an M.D with Distinction in Research and as a member of the Alpha Omega Alpha (AOA) honor society.
He started his internal medicine residency at Stanford University Hospital in 2023. Currently, his interests include the use of AI in opportunistic coronary artery disease assessment, clinical integration of AI-based diagnostic algorithms through clinical trials, and preventive health advocacy through public policy. He plans to pursue a career in cardiology with a focus on advanced computational imaging techniques, medical device development, and advocacy both in his local communities and abroad. -
Chirag Patel, MD, PhD
Member, Cardiovascular Institute
Current Research and Scholarly InterestsNeuro-oncology, Clinical Trials, Tumor Treating Fields (TTFields), Molecular/PET Imaging, Neuroimaging, Immunotherapy, Big Data Analysis
-
Meghna D Patel
Clinical Associate Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsMy current academic focus is in chronic heart failure and ventricular assist device.
-
Debarun Patra
Postdoctoral Scholar, Cardiovascular Institute
BioDebarun Patra is a postdoctoral researcher at Stanford Medicine, with a background in inflammation research. His research focuses on bridging cellular disease mechanisms with in vivo pathophysiology to identify novel therapeutic targets. His current work integrates advanced multi-omics tools, induced pluripotent stem cell (iPSC) technology, and animal models to investigate inflammatory and metabolic diseases (inflammatory bowel disease and MASH).
Debarun's doctoral research at IIT Ropar under Dr. Durba Pal was focused on exploring role of obese adipose tissue microenvironment in chronic inflammation and insulin resistance, particularly evaluating the interactions between adipocytes and macrophages. His findings revealed the critical roles of microRNA-210, cyclophilin-A, and Fetuin-A in adipose tissue inflammation and insulin resistance. -
Arogyaswami Paulraj
Professor (Research) of Electrical Engineering, Emeritus
BioProf. Arogyaswami Paulraj is an Emeritus Professor at Stanford University. Paulraj's legacy is deeply intertwined with the evolution of wireless communication. His groundbreaking work on MIMO (multiple input, multiple output) technology laid the foundation for today's ubiquitous 4G/5G networks and high-speed Wi-Fi.
Paulraj's journey began in the Indian Navy, where he served from 1965 to 1991. During this time, he led the development of the APSOH anti-submarine sonar system and established three key R&D labs for the Indian government. His contributions earned him the prestigious Padma Bhushan award, India's third highest civilian honor.
Following his naval career, Paulraj joined Stanford University as a postdoctoral researcher. His research focus shifted to wireless communication, where he made groundbreaking contributions to MIMO technology. MIMO enables data transmission using multiple antennas, significantly increasing network capacity and data rates.
Paulraj's innovation has been recognized with numerous accolades, including the 2024 Royal Acad. Eng. Prince Philip Medal, the 2023 IET Faraday Medal, the 2014 Marconi Prize, and the 2011 IEEE Alexander Graham Bell Medal. He is also a fellow of nine national academies in engineering, sciences, and the arts, and an inductee of the US Patent Office’s National Inventors Hall of Fame.
Currently, Paulraj continues to contribute to technological advancement. He chairs several committees for the Government of India, focusing on the Indian Semiconductor Mission and Core ICT initiatives. His dedication to research and development continues to shape the future of wireless communication. -
John M. Pauly
Reid Weaver Dennis Professor
BioInterests include medical imaging generally, and magnetic resonance imaging (MRI) in particular. Current efforts are focused on medical applications of MRI where real-time interactive imaging is important. Two examples are cardiac imaging, and the interactive guidance of interventional procedures. Specific interests include rapid methods for the excitation and acquisition of the MR signal, and the reconstruction of images from the data acquired using these approaches.
-
Ronald Pearl
Dr. Richard K. and Erika N. Richards Professor
On Partial Leave from 03/01/2025 To 03/31/2025Current Research and Scholarly InterestsMechanims (molecular and cellular) of pulmonary hypertension, treatment of pulmonary hypertension, treatment of respiratory failure, treatment of septic shock, hemodynamic monitoring
-
Norbert Pelc
Boston Scientific Applied Biomedical Engineering Professor and Professor of Radiology, Emeritus
Current Research and Scholarly InterestsBroadly, Dr. Pelc is interested in the physics, engineering and mathematics of medical imaging, especially computed tomography, digital x-ray imaging, magnetic resonance imaging, and hybrid multimodality systems. His current research is concentrated in the development of computed tomography systems with higher image quality and dose efficiency, in the characterization of system performance, and in the development and validation of new clinical applications.
-
Marco Perez
Associate Professor of Medicine (Cardiovascular Medicine)
BioDr. Marco Perez's research goal is to better understand the fundamental causes of cardiovascular disease through the study of genetics and epidemiology. His group studies the genetic variations and environmental exposures that are associated with conditions such as atrial fibrillation and heart failure. He has led the studies of atrial fibrillation in Women's Health Initiative, one of the largest nation-wide population-based cohorts. He is currently conducting a large study monitoring for silent or asymptomatic atrial fibrillation in women from the WHI randomized to exercise intervention, and was co-PI of the Apple Heart Study, a clinical trial that validated the ability of a smartwatch to detect atrial fibrillation. He is now PI of the Clinical Coordinating Center at Stanford for the REACT-AF which is a clinical trial to evaluate efficacy and safety of a "pill-in-the pocket" approach to anticoagulation for AF using a smartwatch. He is interested in understanding the paradox that atrial fibrillation is less common in African Americans and Hispanics, despite a greater burden of risk factors such as hypertension. As director of the Stanford Inherited Arrhythmia Clinic, he evaluates families with rare inherited arrhythmias associated with sudden death such as Long QT and Brugada Syndromes and explores their links with novel genes. He also studies the genetic causes of very early onset atrial fibrillation. He also studies how best to use the electrocardiogram and imaging modalities using Machine Learning techniques to identify patients at risk for cardiovascular disease. Dr. Perez receives funding from the NIH/NHLBI, Apple Inc., Janssen and the Colson Foundation.
-
Alexander C. Perino
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioAlexander C. Perino MD is a cardiac electrophysiologist, clinical informaticist, and cardiovascular researcher. In his clinical role, Dr. Perino treats patients with heart rhythm disorders at Stanford Health Care, performing catheter ablations and cardiac device implantations. In addition to complex ablation (e.g., atrial fibrillation and ventricular tachycardia ablation), Dr. Perino has expertise implanting leadless pacemakers, subcutaneous ICDs, and conduction system pacing leads (i.e., His bundle and left bundle branch area pacing leads). Dr. Perino is the medical informatics director for the Division of Cardiovascular Medicine at Stanford Health Care, providing informatics direction to improve 1) the quality and safety of cardiovascular care delivery and 2) patient and clinician experience derived from the electronic health record and related information and communication technologies. As a cardiovascular researcher, Dr. Perino uses large datasets to examine quality of care, outcomes, and risk prediction for heart rhythm disorders and cardiovascular disease.
-
VJ Periyakoil, Professor of Medicine
Professor of Medicine (Primary Care and Population Health)
Current Research and Scholarly InterestsMy lab is focused on longevity and healthy aging, multi-cultural palliative care and geriatrics research.
-
Mark Perlroth, MD
Member, Cardiovascular Institute
Current Research and Scholarly Interests1. Adult Congenital Heart Disease
2. Cardiac Transplantation
3. General Cardiology
4. Porphyrias -
Ed Petrossian
Clinical Professor, Cardiothoracic Surgery
Current Research and Scholarly InterestsDr. Petrossian has expertise in complex pediatric and congenital cardiovascular surgical repairs. He has published several journal articles and book chapters with an emphasis on the extracardiac conduit Fontan operation.
-
Ada Poon
Associate Professor of Electrical Engineering
Current Research and Scholarly InterestsOur research focuses on providing theoretical foundations and engineering platforms for realizing electronics that seamlessly integrate with the body. Such systems will allow precise recording or modulation of physiological activity, for advancing basic scientific discovery and for restoring or augmenting biological functions for clinical applications.
-
Richard Popp
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsAcademic-Industrial relations; Ethics of invention.
-
Matthew Porteus
Sutardja Chuk Professor of Definitive and Curative Medicine
BioDr. Porteus was raised in California and was a local graduate of Gunn High School before completing A.B. degree in “History and Science” at Harvard University where he graduated Magna Cum Laude and wrote an thesis entitled “Safe or Dangerous Chimeras: The recombinant DNA controversy as a conflict between differing socially constructed interpretations of recombinant DNA technology.” He then returned to the area and completed his combined MD, PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development with his PhD thesis entitled “Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development.” After completion of his dual degree program, he was an intern and resident in Pediatrics at Boston Children’s Hospital and then completed his Pediatric Hematology/Oncology fellowship in the combined Boston Chidlren’s Hospital/Dana Farber Cancer Institute program. For his fellowship and post-doctoral research he worked with Dr. David Baltimore at MIT and CalTech where he began his studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Following his training with Dr. Baltimore, he took an independent faculty position at UT Southwestern in the Departments of Pediatrics and Biochemistry before again returning to Stanford in 2010 as an Associate Professor. During this time his work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and is considered one of the pioneers and founders of the field of genome editing—a field that now encompasses thousands of labs and several new companies throughout the world. His research program continues to focus on developing genome editing by homologous recombination as curative therapy for children with genetic diseases but also has interests in the clonal dynamics of heterogeneous populations and the use of genome editing to better understand diseases that affect children including infant leukemias and genetic diseases that affect the muscle. Clinically, Dr. Porteus attends at the Lucille Packard Children’s Hospital where he takes care of pediatric patients undergoing hematopoietic stem cell transplantation.
-
Guillem Pratx
Associate Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsThe Physical Oncology Lab is interested in making a lasting impact on translational cancer research by building novel physical tools and methods.
-
James Priest
Adjunct Clinical Assistant Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsThe Priest lab seeks a better understanding of the genetics and pathogenesis of congenital heart disease using translational genomics, big-data, and vertebrate models of cardiac development.
-
Lei (Stanley) Qi
Associate Professor of Bioengineering
BioDr. Lei (Stanley) Qi is an Associate Professor of Bioengineering, an Institute Scholar at Sarafan ChEM-H, and a Chan Zuckerberg Biohub Investigator. He earned B.S. in Physics and Mathematics from Tsinghua University and Ph.D. in Bioengineering from UC Berkeley. Before joining the Stanford faculty in 2014, Dr. Qi was a Systems Biology Faculty Fellow at UCSF.
Dr. Qi is a pioneer in CRISPR technology development, particularly in the areas of epigenetic regulation and chromatin DNA imaging. He invented the first nuclease-deactivated Cas9 (dCas9) system for targeted gene regulation in living cells. His lab has since expanded the CRISPR-dCas toolbox, including new tools and variants like hyperCas12a and the compact CasMINI. These new technologies have enabled CRISPRi and CRISPRa for targeted gene repression and activation in various cells and organisms, large-scale genetic perturbation screens, and precision epigenetic editing in primary cells. His lab also developed technologies for dynamic chromatin DNA imaging in live cells (LiveFISH), 3D genome structure manipulation (CRISPR-GO), and multiplexed transcriptome engineering (MEGA).
Dr. Qi has used these new technologies to make key discoveries in epigenetics, such as the synergistic functions of enhancer elements in cancer gene regulation, metabolic pathways in T cell dysfunction, and novel antivirals against RNA viruses. Dr. Qi’s current research explores synthetic biology, epigenetics, immune cell engineering, and innovative targets for gene therapy in immunology and neurobiology. -
Xiaojie Qiu
Assistant Professor of Genetics
Current Research and Scholarly InterestsAt the Qiu Lab, our mission is to unravel and predict the intricacies of gene regulatory networks and cell-cell interactions pivotal in mammalian cell fate transitions over time and space, with a special emphasis on heart evolution, development, and disease. We are a dynamic and interdisciplinary team, harnessing the latest advancements in machine learning as well as single-cell and spatial genomics by integrating the predictive power of systems biology with the scalability of machine learning,
-
Stephen Quake
Lee Otterson Professor in the School of Engineering and Professor of Bioengineering, of Applied Physics and, by courtesy, of Physics
Current Research and Scholarly InterestsSingle molecule biophysics, precision force measurement, micro and nano fabrication with soft materials, integrated microfluidics and large scale biological automation.
-
Thomas Quertermous, MD
William G. Irwin Professor of Cardiovascular Medicine
Current Research and Scholarly InterestsUnderstanding genetic basis of cardiovascular function and disease.
-
Marlene Rabinovitch
Dwight and Vera Dunlevie Professor of Pediatric Cardiology
Current Research and Scholarly InterestsOur research program seeks to identify the cellular and molecular programs regulating vascular and lung development, through the use of cultured cells and tissues and mouse and rat models. We then determine how these programs are perturbed by genetic abnormalities or injurious processes associated with disease, focusing on pulmonary arterial hypertension (PAH), a fatal complication in children with heart defects, and a condition of unknown etiology primarily in young women.
-
Ralph Rabkin
Professor of Medicine, Emeritus
Current Research and Scholarly InterestsDr Rabkin is examining the mechanism of the acquired resistance to hormones that develops in kidney failure.In particular he is studying the impact of kidney failure on the action of growth hormone and the role of impaired signal transduction as a cause of growth hormone resistance. He is also engaged in the study of growth factors in diabetic kidney disease.
-
Thomas Raffin
The Colleen and Robert Haas Professor in Medicine and Biomedical Ethics, Emeritus
Current Research and Scholarly InterestsDr. Raffin is a clinician, teacher and investigator. He retired as Chief of the Division of Pulmonary and Critical Care Medicine in 2004. His key areas of academic interest include the biology and management of acute lung injury; basic biology of human lung and white cells; and, key issues in biomedical ethics including withholding and withdrawing life support, health care delivery, genomics, genetic screening, and neuroethics.
-
Sameer Raina, MD, MBBS, MBA, FACC
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. Raina is a board-certified cardiologist in the General Cardiology clinic at Stanford Health Care and a member of the Stanford Cardiovascular Institute. He is also a clinical associate professor in the Division of Cardiovascular Medicine.
His clinical interests include preventive cardiology, cardiac rehabilitation, and sports cardiology. In his recent positions at West Virginia University, he established the cardiology telemedicine program during and after the COVID pandemic. He applied his passion for cardiac rehab by creating individualized treatment plans for college athletes recovering from COVID. Dr. Raina is also passionate about building relationships with community doctors. He believes continuous communication is an essential part of excellent patient care.
Dr. Raina’s current research focuses on preventive cardiology, cardiac imaging, and outcomes research. He studies the outcomes of different cardiac interventions in specific patient populations. His research helps identify appropriate treatments for patients who have other conditions in addition to heart disease.
Dr. Raina eagerly anticipates joining the faculty of the Stanford South Asian Translational Heart Initiative (SSATHI). He is excited for the opportunity to address the high risk of cardiovascular diseases among South Asians. He looks forward to applying his clinical and research experience to support SSATHI’s mission to provide advanced care to ethnic populations disproportionately affected by these diseases.
Dr. Raina is a peer reviewer for several prestigious publications, including Neuropsychiatric Disease and Treatment and the International Journal of Chronic Obstructive Pulmonary Disease. He has also been an invited guest speaker at national and international meetings, including those for the International Congress of Cardiology and the World Congress of Cardiothoracic-Renal Diseases.
Dr. Raina is a fellow of the American College of Cardiology (FACC) and a member of the American College of Cardiology. -
Jayakumar Rajadas
Senior Research Scientist - Basic Life, Cardiovascular Institute Operations
BioWith over 30 years of dedicated service in therapeutic innovation, I am passionate about making high-quality, science-supported products accessible to people worldwide. Fueled by this mission, I have founded three laboratories, including the ADDReB Center at the Stanford Cardiovascular Institute, focusing on developing age-reversing regenerative technologies.
My collaborative efforts have led to the creation of therapeutic molecules aimed at treating chronic conditions such as Lyme disease, Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease. I am proud to have clinically tested several of these products, with two now utilized globally.
My research focuses on amyloid chemistry and its related diseases, and I am driven to develop anti-ageing, apelin-based therapeutic interventions.
For a comprehensive overview of my publications, please visit Stanford Profile. https://profiles.stanford.edu/jayakumar-rajadas
Details of my patents are here: https://patents.justia.com/inventor/jayakumar-rajadas -
Chandra Ramamoorthy
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric), Emerita
Current Research and Scholarly InterestsNeuro protection and neurologic outcomes in cardiac patients prior to and concurrent with cardiac surgery and catheterization
-
Thomas Rando, MD, PhD
Professor of Neurology and Neurological Sciences, Emeritus
Current Research and Scholarly InterestsOur laboratory studies the molecular mechanisms regulating stem cell function, the effects of aging on skeletal muscle and skeletal muscle stem cells, and the pathogenesis and experimental therapeutics for hereditary muscle diseases, specifically the muscular dystrophies.
